Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

S O Dolly, AJ Wagner, JC Bendell, HL Kindler, L M Krug, T Y Seiwert, M G Zauderer, Martijn Lolkema, D Apt, R F Yeh, J O Fredrickson, J M Spoerke, H Koeppen, J A Ware, J O Lauchle, HA Burris, JS de Bono

Research output: Contribution to journalArticleAcademicpeer-review

109 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2874-2884
Number of pages11
JournalClinical Cancer Research
Issue number12
Publication statusPublished - 2016

Research programs

  • EMC MM-03-86-08

Cite this